Boehringer Ingelheim Completes Plant Expansion in Georgia
Boehringer Ingelheim, a leading provider of animal health products for poultry, pets and livestock, marked the completion of work on October 9 on the expansion of its site in Athens, Georgia.
The investment, valued at $76 million, doubled the company's capacity to produce vaccines for pets in the United States and around the world.
Read full story at WattAgNet.com
JOIN THE FEDERATION
Elevate your presence in the poultry and egg industry by becoming a member of The Poultry Federation. We invite you to be a part of our community dedicated to fortifying the industry.
MEMBERS LOGIN
Access our exclusive members' portal to register for events, manage your membership, expand your professional network through the directory, and more!